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Background
Aspirin (ASA) hypersensitivity has a complex clinical
presentation with three major phenotypes: aspirin-
exacerbated respiratory disease (AERD; asthma and/or
nasal polyps), chronic urticaria and aspirin-induced ana-
phylaxis. In patients with AERD asthma is often severe
and difficult to control. Moreover, NSAID ingestion may
provoke life-threatening attack. Thus, diagnosing of ASA
hypersensitivity is an important issue. In everyday prac-
tice ASA hypersensitivity is confirmed by oral (OPT),
nasal (NPT) or bronchial provocation tests. However
their protocols vary in terms of maximum cumulative
dose. Besides, phenotype of hypersensitivity is not taken
into consideration when choosing the protocol.
Aim of the study
The aim of this study was to compare responsiveness to
ASA in patients with different phenotypes of ASA hyper-
sensitivity (AERD, chronic urticaria, anaphylaxis).
Patients and methods
238 patients (179 women, 59 men) aged 19-71 with the
history suggesting hypersensitivity to NSAIDS were pro-
voked with aspirin. The group comprised 92 patients with
AERD, 83 with chronic urticaria and 63 with suspicion of
anaphylaxis caused by ASA. Single-blind oral provocation
test was performed according to two-day protocol (day 1-
placebo, day 2- increasing doses of ASA: 50, 100, 150, 300,
400 mg). Anterior rhinomanometry, spirometry and clini-
cal monitoring were used to assess the reaction. The test
was considered positive in case of clinical symptoms of
hypersensitivity, significant decline of FEV1 or positive
nasal response in anterior rhinomanometry.
Results
Provocation test was positive in 81 (34%) patients, includ-
ing 26 with chronic urticaria, 45 with asthma and/or
nasal polyps and 10 with history of anaphylaxis. Propor-
tions of positive results in the subgroups were 31%, 49%
and 16%, respectively. The mean dose provoking reaction
was significantly lower in AERD group compared to
patients with chronic urticaria (212 mg vs. 604 mg,
p<0.05). 36% of positive responders with asthma reacted
to doses ¡Ü200 mg. 19 subjects (8%) responded to pla-
cebo making the provocation impossible to evaluate.
Conclusions
Patients with AERD usually respond to smaller doses of
ASA compared to patients with chronic urticaria. As an
oral provocation test is associated with the risk of ana-
phylactic reaction and its severity is dose-dependent it
may be suggested to introduce new protocol for patients
with severe asthma, based on lower first doses of ASA.
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